|
Status |
Public on Apr 12, 2022 |
Title |
Orthogonal Gene Engineering Enables Novel Synthetic States of Powerful Tumor-rejecting CD8+ T Cells Escaping Canonical Exhaustion |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
To date, no immunotherapy approaches have managed to fully overcome T-cell exhaustion, which remains a mandatory fate for chronically activated effector cells and a major therapeutic challenge. Understanding how to reprogram CD8+ TILs away from exhausted effector states remains an elusive goal. Our work provides for the first-time evidence that orthogonal gene-engineering of T cells to secrete an IL-2-variant binding the IL-2R and the alarmin IL-33 reprogrammed adoptively transferred T cells to acquire a novel, synthetic state, which deviated from canonical exhaustion and displayed superior effector functions. These cells successfully overcame homeostatic barriers in the host, and led – in the absence of lymphodepletion or exogenous cytokine support – to high levels of engraftment and tumor regression. Our work unlocks the novel opportunity of rationally engineering synthetic CD8+ T-cell states endowed with the ability to avoid exhaustion and control advanced solid tumors.
|
|
|
Overall design |
CD45+ bulk TILs were independently sorted at at days 5 (T1), 12 (T2) and 26 (T3) post cell transfer Groups: Non-Treated tumor-bearing mice (G5); Mice received ACT using Untransduced OT1 T cells (G1);Mice received ACT using PD1d/IL2V-secreting OT1 (G2); Mice received ACT using PD1d/33-secreting OT1 (G3); Mice received ACT using PD1d/2V/33-secreting OT1 (G4)
|
|
|
Contributor(s) |
Corria-Osorio J, Carmona SJ, Andreatta M, Coukos G |
Citation(s) |
37081150 |
|
Submission date |
Apr 09, 2022 |
Last update date |
Apr 25, 2023 |
Contact name |
Jesus Corria-Osorio |
E-mail(s) |
angeldejesus.corriaosorio@unil.ch
|
Phone |
0216925964
|
Organization name |
Ludwig Institute for Cancer Research. Lausanne Branch. UNIL
|
Department |
Department of Fundamental Oncology
|
Lab |
System T cells (George Coukos' Lab)
|
Street address |
Chemin des Boveresses 155
|
City |
Lausanne |
State/province |
Vaud |
ZIP/Postal code |
1066 |
Country |
Switzerland |
|
|
Platforms (1) |
GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
|
Samples (8)
|
|
Relations |
BioProject |
PRJNA825099 |